Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03978884

Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes

An Open Label, Single Arm Prospective Study to Evaluate Efficacy and Safety of Losartan Based Therapy Reslio® (Losartan) and Resilo-h® (Losartan+Hydrochlorthiazide) in Diabetic and Uncontrolled Hypertensive Patients

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
The University of The West Indies · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

To study antihypertensive efficacy of 12 weeks of Losartan based therapy Resilo (Losartan) and Resilo-H (Losartan+ Hydrochlorothiazide) in uncontrolled hypertensive and diabetic hypertensive patients.

Detailed description

200 hundred Subjects will be treated with a dose escalation regimen to achieve a target blood pressure. Subjects with mild hypertension at baseline will be started with losartan 50 mgs and those with severe hypertension will be started with losartan H 100/25. After 6 weeks they will titrated if goal blood pressure not achieved. For Mild hypertensive group this will be with losartan H 100/25 and for severe hypertensive group this will by addition of amlodipine 5 mg to regime. Subjects with mild hypertension and diabetes at baseline will be started with losartan H 50/12.5 mg and those with severe hypertension with diabetes will be started with losartan H 100/25. After 6 weeks they will be titrated if goal blood pressure not achieved. For Mild hypertensive-diabetic group this will be with Resilo H 100/25 and for severe hypertensive group this will by addition of amlodipine 5 mg to regime. Target Blood Pressure is systolic \< 140 mmhg and diastolic \< 90 mmHg if age \< 60 years and systolic \< 150 mmHg and diastolic \< 90 mmHg if age \>60 years.

Conditions

Interventions

TypeNameDescription
DRUGLosartan 50Mg TabTake 1 tab daily
DRUGLosartan/Hydrochlorothiazide 50 Mg-12.5 Mg ORAL TABLETTake 1 tab daily
DRUGLosartan/Hydrochlorothiazide 100 Mg-25 Mg ORAL TABLETTake 1 tab daily
DRUGAmlodipine 5mgTake 1 tablet daily

Timeline

Start date
2019-06-01
Primary completion
2020-05-31
Completion
2020-12-31
First posted
2019-06-07
Last updated
2020-09-03

Locations

1 site across 1 country: Jamaica

Source: ClinicalTrials.gov record NCT03978884. Inclusion in this directory is not an endorsement.